Amiodarone Use in Bradycardic Patients

Absolute Contraindications

Severe sinus node dysfunction is an absolute contraindication to amiodarone use, as recommended by the American College of Cardiology 1
Second- or third-degree AV block without a functioning pacemaker is an absolute contraindication, according to the European Society of Cardiology 1
Patients with these conditions should not receive amiodarone unless a temporary or permanent pacemaker is already in place, as stated by the European Heart Journal 2

Bradycardia is listed as a potential adverse effect for both oral and intravenous formulations of amiodarone, as reported by the American Academy of Family Physicians 3

For life-threatening ventricular arrhythmias (VT/VF), the potential benefit of amiodarone may outweigh the bradycardia risk, as recommended by the American Heart Association 3
Amiodarone is recommended as first-choice therapy for refractory VF/VT after 3 initial shocks, even though bradycardia is a known risk, according to the European Resuscitation Council 2
In patients with atrial fibrillation and heart failure, amiodarone can be used for rate control when other measures fail, as suggested by the American College of Cardiology 4

Treatment with amiodarone should occur in a setting where a temporary pacemaker is immediately available, as recommended by the European Society of Cardiology 2
Continuous ECG monitoring is mandatory, especially during intravenous administration, as stated by the American Academy of Family Physicians 3
Monitor heart rate at approximately weekly intervals during oral therapy using pulse checks, event recorders, or office ECG tracings, as recommended by the American Heart Association 5
Reduce or discontinue other rate-controlling medications (beta-blockers, calcium channel blockers, digoxin) when initiating amiodarone, as suggested by the American College of Cardiology 5

Baseline ECG documentation before initiation is essential, as recommended by the American College of Cardiology 1
Monitor PR interval closely when using amiodarone, as it can prolong AV conduction, as stated by the American Heart Association 5
Heart rate surveillance should continue throughout the first week of treatment and regularly thereafter, as recommended by the European Society of Cardiology 1

Extreme caution is required when combining amiodarone with beta-blockers (e.g., propranolol, atenolol), as they have a synergistic effect on AV node, increasing the risk of bradycardia, sinus arrest, and AV block, as reported by the American College of Cardiology 5
Calcium channel antagonists (verapamil, diltiazem) should be used with caution, as they can potentiate bradycardia and AV block, as stated by the American Heart Association 5
Digoxin dose should be reduced by approximately 50% when co-administered with amiodarone, as recommended by the American College of Cardiology 5

Beta-blockers are recommended as first-line therapy for postoperative atrial fibrillation, unless contraindicated, as stated by the American College of Cardiology 6
Amiodarone can be used for rate control in acute settings with caution in patients with overt congestion or hypotension, as suggested by the American College of Cardiology 6
The combination of digoxin and amiodarone is reasonable for controlling both resting and exercise heart rate in heart failure patients, as recommended by the American College of Cardiology 6

Do not use amiodarone with multiple other rate-controlling agents simultaneously without careful dose adjustments, as warned by the American Heart Association 5
The bradycardia induced by amiodarone is more common in women than men, as reported by the American College of Cardiology 5